Human Genome Epidemiology Literature Finder
Records 1 - 6 (of 6 Records) |
Query Trace: CALM3[original query] |
---|
A new polymorphism in human calmodulin III gene promoter is a potential modifier gene for familial hypertrophic cardiomyopathy. European heart journal 2009 Jul 30 (13): 1648-55. Friedrich Felix W, Bausero Pedro, Sun Yuli, Treszl Andras, Krämer Elisabeth, Juhr Denise, Richard Pascale, Wegscheider Karl, Schwartz Ketty, Brito Dulce, Arbustini Eloisa, Waldenström Anders, Isnard Richard, Komajda Michel, Eschenhagen Thomas, Carrier Lucie, |
Identification of sequence polymorphisms in CALM2 and analysis of association with hip osteoarthritis in a Japanese population. Journal of bone and mineral metabolism 2010 Sep 28 (5): 547-53. Mototani Hideyuki, Iida Aritoshi, Nakamura Yusuke, Ikegawa Shi |
Comprehensive analysis of the association of EGFR, CALM3 and SMARCD1 gene polymorphisms with BMD in Caucasian women. PloS one 2014 9 (11): e112358. Zhou Qiu-Hong, Zhao Lan-Juan, Wang Ping, Badr Rhamee, Xu Xiao-Jing, Bu Feng-Xiao, Lappe Joan, Recker Robert, Zhou Yu, Ye An, Zhou Bo-Ti |
Clinical implications of nonsarcomeric gene polymorphisms in hypertrophic cardiomyopathy. European journal of clinical investigation 2015 Nov . García-Honrubia Antonio, Hernández-Romero Diana, Orenes-Piñero Esteban, Romero-Aniorte Ana Isabel, Climent Vicente, García Miriam, Garrigos-Gómez Noemí, Moro Concepción, Valdés Mariano, Marín Francis |
ACE2, CALM3 and TNNI3K polymorphisms as potential disease modifiers in hypertrophic and dilated cardiomyopathies. Molecular and cellular biochemistry 2017 Jul . Kumar Amit, Rani Bindu, Sharma Rajni, Kaur Gurjeet, Prasad Rishikesh, Bahl Ajay, Khullar Mad |
Correction to: ACE2, CALM3 and TNNI3K polymorphisms as potential disease modifiers in hypertrophic and dilated cardiomyopathies. Molecular and cellular biochemistry 2018 11 450 (1-2): 209-210. Kumar Amit, Rani Bindu, Sharma Rajni, Kaur Gurjeet, Prasad Rishikesh, Bahl Ajay, Khullar Mad |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: